Interesting malignant renal tumours: a tripod of cases
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231647Keywords:
Renal tumors, Kidney neoplasms, Renal cell carcinoma, Tubulocystic renal cell carcinoma, Chromophobe, LeiomyosarcomaAbstract
Renal malignancy is the 15th leading cause of annual deaths, with late detection and misdiagnosis leading to decreased patient survival. We hereby present three cases of malignant renal tumours which grabbed our attention because of their rarity and interesting presentation. Case 1-A 38 year old male presented with palpable lump in right flank, CT revealed a multilocular cystic lesion in right kidney, along with horse-shoe kidneys. In view of renal biopsy suggesting Tubulocystic carcinoma, patient underwent nephrectomy and diagnosis confirmed to be the same histomorphologically as well as immunohistochemically using AMACR and PR. Case 2-A 77-year-old male had lower urinary tract symptoms due to prostatomegaly, and a left renal mass and small hepatic cysts were detected incidentally. Kidney function was normal. Microscopy showed Chromophobe renal cell carcinoma, which was confirmed with immunohistochemical markers CK7 and CKIT. Case 3-A 50 year female presented with recurrent lump in her left flank, CT confirmed a huge left renal fossa mass. Biopsy showed features of malignant mesenchymal neoplasm consistent with leiomyosarcoma based on immunohistochemical panel of vimentin, h-Caldesmon, SMA, EMA, HMB-45 and S100, which helped in differentiating it from tumours like angiomyolipoma. Renal tumours have varied morphological overlapping and it is important to rule out close differentials using immunohistochemistry before coming to a diagnosis. Awareness of such presentations and findings can broaden our understanding of renal tumours which can help in early and accurate diagnosis for better outcome of the patient.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2021;71(3):209-49.
WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed. 2022;8.
Banerjee I, Yadav SS, Tomar V, Yadav S, Talreja S. Tubulocystic renal cell carcinoma: a great imitator. Reviews Urol. 2016;18(2):118.
Zhao M, Teng X, Ru G, Zhao Z, Hu Q, Han L et al. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature. Int J Clin Experimental Pathol. 2015;8(9):11124.
Vera‐Badillo FE, Conde E, Duran I. Chromophobe renal cell carcinoma: a review of an uncommon entity. Int J Urol. 2012;19(10):894-900.
Zafar R, Manthri S, Shurbaji MS. Renal leiomyosarcoma. InStatPearls. StatPearls Publishing. 2022.
FATHIMA S, KAMATH S. An Aggressive Urothelial Carcinoma in a Horseshoe Kidney-A Case Report. J Clin Diagnostic Res. 2020;14(7).
Turbiner J, Amin MB, Humphrey PA, Srigley JR, De Leval L, Radhakrishnan A et al. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surgical Pathol. 2007;31(4):489-500.
Moazzam M, Ather MH, Hussainy AS. Leiomyosarcoma presenting as a spontaneously ruptured renal tumor-case report. BMC Urol. 2002;2(1):1-3.
De Sevilla F, Muniz R, Palou J, Banús JM, Alegre J, Garcia A et al. Renal leiomyosarcoma in a patient with tuberous sclerosis. Urologia Int. 1988;43(1):62-4.
Darlington D, Anitha FS. Atypical presentation of renal leiomyosarcoma: a case report. Cureus. 2019;19;11(8).
Valery JR, Tan W, Cortese C. Renal leiomyosarcoma: a diagnostic challenge. Case Rep Oncological Med. 2013;2013.